Regent Pacific Group Ltd. Share Price Hong Kong S.E.
Equities
0575
KYG7478U1388
Pharmaceuticals
Sales 2022 | 35K 273K 2.92M | Sales 2023 | 291K 2.27M 24.27M | Capitalization | 18.13M 142M 1.51B |
---|---|---|---|---|---|
Net income 2022 | -36M -281M -3B | Net income 2023 | -25M -195M -2.08B | EV / Sales 2022 | 1,045 x |
Net Debt 2022 | 12.29M 96.03M 1.03B | Net cash position 2023 | 1.22M 9.53M 102M | EV / Sales 2023 | 58.1 x |
P/E ratio 2022 |
-0.67
x | P/E ratio 2023 |
-0.71
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 40.23% |
Managers | Title | Age | Since |
---|---|---|---|
Jamie Gibson
CEO | Chief Executive Officer | 58 | 01/96/01 |
Jim Mellon
FOU | Founder | 68 | 01/90/01 |
Yui Fui Wong
DFI | Director of Finance/CFO | 49 | 01/11/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jim Mellon
FOU | Founder | 68 | 01/90/01 |
Jamie Gibson
CEO | Chief Executive Officer | 58 | 01/96/01 |
Stawell Searle
BRD | Director/Board Member | 80 | 01/01/01 |
1st Jan change | Capi. | |
---|---|---|
+55.32% | 815B | |
+43.59% | 641B | |
-6.75% | 352B | |
+13.56% | 314B | |
+10.68% | 303B | |
+16.14% | 242B | |
+2.09% | 224B | |
+12.96% | 218B | |
+8.48% | 168B |